Emergent BioSolutions (EBS) Tops Q1 EPS by 142c, provides guidanvce
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.28 --0%
EPS Growth %: -31.3%
Financial Fact:
Interest expense: -2.05M
Today's EPS Names:
CRMT, More
EPS Growth %: -31.3%
Financial Fact:
Interest expense: -2.05M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.59, $1.42 better than the analyst estimate of ($0.83). Revenue for the quarter came in at $300.4 million versus the consensus estimate of $185.4 million.
GUIDANCE:
Emergent BioSolutions sees FY2024 revenue of $1-1.1 billion, versus the consensus of $1.015 billion.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Constellation Brands (STZ) Tops Q1 EPS by 18c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
